Trupanion Inc. (NASDAQ:TRUP) is one of the best fintech stocks to invest in. On February 12, Trupanion delivered the full-year 2025 financial report, highlighted by ~$1 billion in annual subscription revenue. Total revenue for the year grew 12% to over $1.4 billion, while net income reached $19.4 million, which was a sharp recovery from the $9.6 million net loss reported in 2024. This financial turnaround was driven by a 15% annual subscription-adjusted operating margin and a 33% increase in adjusted ope ...

Core Insights - Trupanion, Inc. is participating in two upcoming investor conferences, showcasing its leadership in pet medical insurance [1][3] Company Overview - Trupanion is a leader in medical insurance for cats and dogs in the U.S., Canada, and parts of Continental Europe, with over 1,000,000 pets enrolled [2] - The company has been operational for over two decades, providing pet owners with peace of mind regarding financial stress related to pet recovery [2] - Trupanion offers unlimited payouts on eligible expenses for the life of pets and is the only North American provider with technology to pay veterinarians directly at checkout [2] - The company was founded in 2000 and is headquartered in Seattle, WA, with policies issued by its wholly-owned insurance entities [2] Upcoming Events - Trupanion's management team, including CEO Margi Tooth and CFO Fawwad Qureshi, will present at the BofA Securities 2026 Animal Health Summit on February 26, 2026, at 12:25 p.m. ET [3] - The company will also present at the 47th Annual Raymond James Institutional Investor Conference in Orlando on March 2, 2026, at 9:15 a.m. ET [3]

Core Viewpoint - Trupanion reported quarterly earnings of $0.13 per share, missing the Zacks Consensus Estimate of $0.14 per share, but showing an increase from $0.04 per share a year ago [1][2] Earnings Performance - The earnings surprise for the quarter was -9.72%, while the previous quarter saw a positive surprise of +116.67% when actual earnings were $0.13 compared to an expected $0.06 [2] - Over the last four quarters, Trupanion has surpassed consensus EPS estimates three times [2] Revenue Performance - Trupanion's revenues for the quarter ended December 2025 were $376.85 million, exceeding the Zacks Consensus Estimate by 0.28% and up from $337.31 million year-over-year [3] - The company has topped consensus revenue estimates four times over the last four quarters [3] Stock Performance and Outlook - Trupanion shares have declined approximately 13.5% since the beginning of the year, contrasting with the S&P 500's gain of 1.4% [4] - The future performance of the stock will largely depend on management's commentary during the earnings call [4] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.08 on revenues of $377.47 million, and for the current fiscal year, it is $0.51 on revenues of $1.58 billion [8] - The estimate revisions trend for Trupanion was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [7] Industry Context - The Insurance - Accident and Health industry, to which Trupanion belongs, is currently in the top 36% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [9]

Core Insights - Trupanion, Inc. reported strong financial results for Q4 and the full year 2025, achieving a total revenue of $376.9 million in Q4, a 12% increase year-over-year, and $1.439 billion for the full year, also a 12% increase compared to 2024 [7][20] - The company reached its annual margin target of 15% in 2025, while subscription revenue grew by 15% in Q4 and 16% for the full year [2][7] - Trupanion's net income for Q4 was $5.6 million, or $0.13 per share, compared to $1.7 million, or $0.04 per share, in Q4 2024, and for the full year, net income was $19.4 million, a significant turnaround from a net loss of $9.6 million in 2024 [7][20] Financial Highlights - Total revenue for Q4 2025 was $376.9 million, up 12% from Q4 2024, while full-year revenue reached $1.439 billion, also a 12% increase [7][20] - Subscription business revenue in Q4 was $261.4 million, a 15% increase year-over-year, and $989.3 million for the full year, a 16% increase [7][20] - Adjusted EBITDA for Q4 was $21.8 million, compared to $19.4 million in Q4 2024, and for the full year, it was $70.1 million, up from $46.1 million in 2024 [7][20] Operational Metrics - Total enrolled pets as of December 31, 2025, was 1,647,565, a decrease of 2% from the previous year, while subscription enrolled pets increased by 5% to 1,096,173 [7][20] - Monthly average revenue per pet rose to $80.79 in 2025 from $72.98 in 2024, and the average pet acquisition cost increased to $288 from $235 [20] - The average monthly retention rate improved slightly to 98.34% in 2025 from 98.25% in 2024 [20] Cash Flow and Investments - Operating cash flow for Q4 2025 was $29.3 million, compared to $23.7 million in Q4 2024, and for the full year, it was $89.5 million, up from $48.3 million in 2024 [7][20] - Free cash flow for Q4 was $25.3 million, an increase from $21.8 million in Q4 2024, and for the full year, it was $75.4 million, compared to $38.6 million in 2024 [7][20] - The company held $370.7 million in cash and short-term investments as of December 31, 2025, with $50 million held outside insurance entities [7][20]

Core Viewpoint - Trupanion (TRUP) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Impact - The Zacks rating system focuses on changes in earnings estimates, which are strongly correlated with near-term stock price movements, particularly due to institutional investors' reliance on these estimates for valuation [4][6]. - Trupanion's rising earnings estimates and the subsequent rating upgrade suggest an improvement in the company's underlying business, likely leading to an increase in stock price [5][10]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, indicating superior earnings estimate revisions, which positions Trupanion favorably for potential market-beating returns [9][10]. Earnings Estimate Revisions for Trupanion - Trupanion is expected to earn $0.48 per share for the fiscal year ending December 2025, with no year-over-year change, while the Zacks Consensus Estimate has increased by 46.9% over the past three months [8].

Core Viewpoint - Trupanion, Inc. will report its financial results for the fourth quarter and full year of 2025 on February 12, 2026, after market close, followed by a conference call to discuss the results and management observations [1][2]. Company Overview - Trupanion is a leader in medical insurance for pets, specifically cats and dogs, operating in the United States, Canada, and parts of Continental Europe, with over 1,000,000 pets currently enrolled [4]. - The company has been providing pet owners with peace of mind for over two decades, focusing on high-value pet medical insurance with unlimited payouts for the life of the pets [4]. - Trupanion is the only North American provider with technology that allows for direct payment to veterinarians at the time of checkout [4]. - The company was founded in 2000 and is headquartered in Seattle, WA, and is listed on NASDAQ under the symbol "TRUP" [4]. Conference Call Details - The conference call will begin shortly after 1:30 p.m. PT / 4:30 p.m. ET on February 12, 2026, and will be accessible via a live webcast on Trupanion's Investor Relations site [1][2]. - Participants can join the call by dialing specific numbers for the United States and international access, with a telephonic replay available afterward [3].

Core Insights - Trupanion's President and CEO, Margi Tooth, has been recognized as one of the Puget Sound Business Journal's 2025 Women of Influence, highlighting her contributions to the industry and community [1][2] - The recognition underscores Trupanion's mission to assist pet owners in managing the financial aspects of pet care, promoting access to high-quality veterinary services [2][4] Company Overview - Trupanion is a leading provider of medical insurance for pets in North America, with over 1,000,000 pets currently enrolled [5] - The company has been operational for over two decades, focusing on providing peace of mind to pet owners by offering unlimited payouts for their pets' medical needs [5] Financial Impact - Trupanion has paid over $3.5 billion in veterinary invoices, showcasing the effectiveness of comprehensive pet insurance in alleviating financial burdens during medical emergencies [6] - The company has successfully reached over 1 million subscription pets globally, indicating a strong market presence and demand for transparent pet insurance [6] Technological Innovation - Trupanion has developed patented technology that allows for direct payment to veterinarians at the time of checkout, enhancing the efficiency of the payment process and allowing focus on pet recovery [6] Community Engagement - The company emphasizes a strong, caring company culture and has been recognized for its employee well-being initiatives [3] - Trupanion's commitment to community involvement is demonstrated through partnerships, such as with the Seattle Reign FC, aimed at promoting local equity [4]

Company Performance - Trupanion reported quarterly earnings of $0.13 per share, exceeding the Zacks Consensus Estimate of $0.06 per share, and up from $0.03 per share a year ago, indicating a significant improvement [1] - The earnings surprise for the quarter was +116.67%, following a previous quarter where the company reported earnings of $0.22 per share against an expected loss of $0.03, resulting in a surprise of +833.33% [2] - The company achieved revenues of $366.92 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.58% and up from $327.46 million year-over-year [3] Future Outlook - The sustainability of Trupanion's stock price movement will largely depend on management's commentary during the earnings call and future earnings expectations [4] - Current consensus EPS estimate for the upcoming quarter is $0.10 on revenues of $369.2 million, and for the current fiscal year, it is $0.35 on revenues of $1.43 billion [8] - The estimate revisions trend for Trupanion was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [7] Industry Context - The Insurance - Accident and Health industry, to which Trupanion belongs, is currently ranked in the bottom 26% of over 250 Zacks industries, suggesting potential challenges ahead [9]

Core Insights - Trupanion, Inc. reported record quarterly profitability and continued growth in subscription pet enrollments for the third consecutive quarter, indicating a strong financial foundation and commitment to sustainable growth [2][6]. Financial Highlights - Total revenue for Q3 2025 was $366.9 million, a 12% increase compared to Q3 2024 [8]. - Subscription business revenue reached $252.7 million, reflecting a 15% increase year-over-year [8]. - Net income for Q3 2025 was $5.9 million, or $0.14 per basic share, compared to $1.4 million, or $0.03 per basic share, in Q3 2024 [8]. - Adjusted EBITDA for Q3 2025 was $19.6 million, up from $14.5 million in Q3 2024 [8]. - Operating cash flow was $29.2 million, compared to $15.3 million in Q3 2024 [8]. Business Metrics - Total enrolled pets as of September 30, 2025, was 1,654,414, a decrease of 2% from the previous year [8]. - Subscription enrolled pets increased by 5% to 1,082,412 [8]. - Monthly average revenue per pet rose to $79.84 from $71.94 year-over-year [24]. - Average pet acquisition cost increased to $278 from $227 [24]. - Average monthly retention rate improved slightly to 98.33% from 98.29% [24]. Debt and Financial Flexibility - Trupanion secured a new three-year $120 million credit facility with PNC Bank, which has a lower interest rate than the previous facility, enhancing financial flexibility [6][7]. - The new credit facility is expected to support strategic initiatives and operational investments, reflecting the company's commitment to prudent financial management [7]. Year-to-Date Performance - For the first nine months of 2025, total revenue was $1,062.5 million, a 12% increase compared to the same period in 2024 [8]. - Subscription business revenue for the first nine months was $727.9 million, a 16% increase year-over-year [8]. - Net income for the first nine months was $13.8 million, compared to a net loss of $(11.3) million in the same period of 2024 [8].

Core Insights - Aflac reported quarterly earnings of $2.49 per share, exceeding the Zacks Consensus Estimate of $1.80 per share, and showing an increase from $2.16 per share a year ago, resulting in an earnings surprise of +38.33% [1] - The company generated revenues of $4.74 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.59%, and significantly up from $2.95 billion year-over-year [2] - Aflac's stock has underperformed the market with a gain of about 3.4% since the beginning of the year, compared to the S&P 500's gain of 16.5% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.70 on revenues of $4.47 billion, and for the current fiscal year, it is $6.91 on revenues of $17.81 billion [7] - The estimate revisions trend for Aflac was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Insurance - Accident and Health industry, to which Aflac belongs, is currently ranked in the top 39% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]